6th Circ. Affirms Toss Of Generic Drug Labeling Suits
The Sixth Circuit on Thursday upheld the dismissal of three suits bringing state failure-to-warn claims related to generic versions of heartburn medication Reglan against Barr Pharmaceuticals Inc. and others, citing the...To view the full article, register now.
Already a subscriber? Click here to view full article